The downregulation of GIPC1 in cervical cancer with HPV-18 infection can lead to the resistance to cytostatic transforming growth factor β signaling through TGFβR3 destabilization (Katoh, 2013). This evidence concerns the gene TGFBR3 and cervical cancer.